文献速递系统性红斑狼疮类风湿关节炎脊柱关节炎

系统性硬化症及相关风湿病中Fcγ受体表达升高增强促炎性巨噬细胞吞噬作用

Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseases.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

本研究通过单细胞RNA测序分析健康对照与系统性硬化症患者皮肤和肺巨噬细胞,并体外分化健康对照、系统性硬化症、类风湿关节炎、银屑病关节炎及中轴型脊柱关节炎患者单核细胞来源巨噬细胞,发现系统性硬化症巨噬细胞FCGR基因表达升高、FcγR介导吞噬通路富集,FcγRI和FcγRII升高驱动吞噬活性增强及IL-6炎症,尼达尼布可降低FcγRI表达。

要点

  • 系统性硬化症皮肤FCGR3Ahi巨噬细胞FCGR基因升高且促炎标志物伴随。
  • 系统性硬化症、类风湿关节炎和银屑病关节炎患者巨噬细胞体外吞噬活性增强。
  • FcγRI和FcγRII升高驱动吞噬活性及IL-6炎症,尼达尼布降低FcγRI表达。

核心结论

  • 表达FcγR的巨噬细胞是系统性硬化症中吞噬作用和炎症反应的驱动因素。
  • 这些巨噬细胞的失调激活可能导致风湿病中持续性炎症和纤维化,提示新的潜在治疗途径。

研究设计与样本

  • 分析健康对照和系统性硬化症患者皮肤与肺巨噬细胞的单细胞RNA测序数据集(GSE138669/GSE212109)。
  • 从健康对照、系统性硬化症、类风湿关节炎、银屑病关节炎和中轴型脊柱关节炎患者的CD14+单核细胞分化人单核细胞来源巨噬细胞。
  • 部分实验中,人单核细胞来源巨噬细胞用0.1 μM尼达尼布预处理。
  • 用pHrodo生物颗粒和流式细胞术定量吞噬活性,流式细胞术评估巨噬细胞表面标志物,Western blot评估NF-κB信号,RT-qPCR评估基因表达。

主要发现

  • 单细胞RNA测序数据集分析显示系统性硬化症受累器官中存在促吞噬特征。
  • 系统性硬化症巨噬细胞,尤其是皮肤FCGR3Ahi簇,FCGR基因表达升高、FcγR介导吞噬通路富集并伴随促炎标志物。
  • 该表型扩展至合并间质性肺病的系统性硬化症患者FCN1hi肺巨噬细胞,提示系统性促炎和吞噬特征。
  • 来自系统性硬化症、类风湿关节炎和银屑病关节炎患者的人单核细胞来源巨噬细胞在体外显示增强的吞噬活性。
  • FcγRI和FcγRII水平升高被确定为吞噬活性增加及后续IL-6驱动炎症的关键驱动因素。

临床怎么用

  • 作者认为FcγR表达巨噬细胞是系统性硬化症吞噬和炎症反应的驱动因素,失调激活可能导致持续性炎症和纤维化。
  • 作者认为尼达尼布降低FcγRI表达提示其在减弱吞噬过程中有潜在治疗益处。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the pro-phagocytic phenotype of macrophages in SSc and other rheumatic diseases by examining their activation, signalling pathways and treatment responses, with the goal of uncovering mechanisms that drive enhanced phagocytosis. METHODS: Single-cell RNA sequencing (scRNA-seq) datasets (GSE138669/GSE212109) from skin and lung macrophages of healthy controls (HC) and SSc patients were analysed. Human monocyte-derived macrophages (hMDMs) were differentiated from CD14+ monocytes from HC, SSc, RA, PsA, and axSpA patients. In selected experiments, hMDMs were pretreated with 0.1 μM nintedanib. Phagocytic activity was quantified using pHrodo bioparticles and flow cytometry. Macrophage surface markers were evaluated by flow cytometry, NF-κB signalling by Western blot and gene expression by RT-qPCR. RESULTS: Analysis of scRNA-seq datasets revealed a pro-phagocytic signature in SSc-affected organs. SSc macrophages, particularly the FCGR3Ahi cluster in skin, exhibited elevated expression of FCGR genes and enriched FcγR-mediated phagocytosis pathways, accompanied by pro-inflammatory markers. This phenotype extended to FCN1hi lung macrophages in SSc patients with interstitial lung disease, indicating a systemic pro-inflammatory and phagocytic profile. hMDMs from SSc, RA and PsA patients demonstrated enhanced phagocytic activity in vitro. Elevated FcγRI and FcγRII levels were identified as key drivers of increased phagocytic activity and subsequent IL-6-driven inflammation. Nintedanib showed reduction in FcγRI expression, suggesting its potential therapeutic benefit in attenuating the phagocytic process. CONCLUSION: This study highlights FcγR-expressing macrophages as drivers of phagocytosis and inflammatory responses in SSc. Dysregulated activation of these macrophages could lead to persistent inflammation and fibrosis in rheumatic diseases, highlighting new potential therapeutic approaches.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hukara A, Bonazza GA, Tabib T, et al. Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseases. Rheumatology (Oxford). 2025. PMID: 39672802. doi:10.1093/rheumatology/keae688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。